How We Treat Febrile Neutropenia in Patients Receiving Cancer Chemotherapy

Although improved supportive care has reduced mortality associated with febrile neutropenia, it continues to cause chemotherapy limitations, morbidity, mortality, and cost among patients with cancer.

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lyman, Gary H., Rolston, Kenneth V. I.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2010
Konular:
Current Clinical Issues
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2868641/
https://ncbi.nlm.nih.gov/pubmed/20808559
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JOP.091092
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller